Table 8.
PHAs (F=95) |
CRs (F=142) |
Others (F=89) b |
Total (F=326) c |
|
---|---|---|---|---|
# of PHAs named in network at follow-up (mean) | (.885) | (1.345) | (1.048) | (1.110)* |
# of CRs named in network at follow-up (mean) | (.207) | (.147) | (.383) | (.219)* |
% of network members gave information to | 72.3 | 32.8 | 21.2 | 40.6** |
% of network members gave demonstration/materials to | 66.9 | 19.3 | 10.3 | 29.9** |
% of network members received information from | 26.3 | 36.0 | 38.7 | 33.4* |
% of network members received demo/materials from | 18.9 | 34.4 | 29.1 | 27.7* |
% of network members received prevention from in primary drug use site | 33.1 | 39.4 | 27.8 | 33.8 |
Significance is indicated for comparisons between groups.
Includes CRs of all untrained PHAs (i.e., received 0–4 training sessions) and PHAs who attended no training sessions. PHAs who attended 1–4 sessions are excluded.
PHAs who attended only 1–4 sessions were included in the follow-up total.
p < .05;
p < .001